The molecular defect in the abnormal fibrinogen Dusart (Paris V) that is associated with thrombophilia was determined by sequence analysis of genomic DNA that had been amplified using the polymerase chain reaction. The propositus was heterozygous for a single base change (C-->T) in the A alpha-chain gene, resulting in the amino acid substitution A alpha 554 Arg-->Cys. Restriction analysis of the amplified DNA derived from the family members showed that his father and his two sons were also heterozygous. Electron microscopic studies on fibrin formed from purified fibrinogen Dusart demonstrated fibers that were much thinner than in normal fibrin. In contrast to the previously observed defective binding of plasminogen, the binding of thrombospondin to immobilized fibrinogen Dusart was similar to that of normal fibrinogen. Immunoblot analysis of plasma fibrinogen demonstrated that a substantial part of the fibrinogen Dusart molecules were disulfide-linked to albumin. The plasma of the affected family members also contained fibrinogen-albumin complexes. Furthermore, small amounts of high molecular weight complexes containing fibrinogen were detected in all the heterozygous individuals. These data indicate that the molecular abnormality in fibrinogen Dusart (A alpha 554 Arg-->Cys) results in defective lateral association of the fibrin fibers and disulfide-linked complex formation with albumin, and is associated with a family history of recurrent thrombosis in the affected individuals.
J Koopman, F Haverkate, J Grimbergen, S T Lord, M W Mosesson, J P DiOrio, K S Siebenlist, C Legrand, J Soria, C Soria
Title and authors | Publication | Year |
---|---|---|
Fibrinogen post‐translational modifications are biochemical determinants of fibrin clot properties and interactions
Tenopoulou M |
The Febs Journal | 2024 |
Germline VWF/MPRIP and somatoplasm FGA variants synergically confer susceptibility to non-traumatic osteonecrosis of the femoral head.
Wang D, Gu L, Zheng J, Zhang Q, Xu Q, Li R, Song D, Ha C, Zhang Q, Yin H, Xu M, Wang H, Li W, Yuan Z, Yang C, Gu M |
Scientific Reports | 2023 |
Thromboses and Hemostasis Disorders Associated with Coronavirus Disease 2019: The Possible Causal Role of Cross-Reactivity and Immunological Imprinting
D Kanduc |
2021 | |
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding
MV Bor, S Feddersen, IS Pedersen, JJ Sidelmann, SR Kristensen |
Seminars in thrombosis and hemostasis | 2021 |
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders
RJ Fish, C Freire, CD Sanza, M Neerman-Arbez |
International journal of molecular sciences | 2021 |
The genetics of venous thromboembolism: a systematic review of thrombophilia families
Y Zhang, Z Zhang, S Shu, W Niu, W Xie, J Wan, Z Zhai, C Wang |
Journal of Thrombosis and Thrombolysis | 2020 |
Missing regions within the molecular architecture of human fibrin clots structurally resolved by XL-MS and integrative structural modeling
O Klykov, C van der Zwaan, AJ Heck, AB Meijer, RA Scheltema |
Proceedings of the National Academy of Sciences | 2020 |
Fibrinogen αC domain: Its importance in physiopathology
J Soria, S Mirshahi, SQ Mirshahi, R Varin, LL Pritchard, C Soria, M Mirshahi |
Research and Practice in Thrombosis and Haemostasis | 2019 |
c.259A>C in the fibrinogen gene of alpha chain (FGA) is a fibrinogen with thrombotic phenotype O Salomon, O Barel, E Eyal, RS Ganor, Y Kleinbaum, M Shohat |
The Application of Clinical Genetics | 2019 |
Homocysteine Modification in Protein Structure/Function and Human Disease
H Jakubowski |
Physiological reviews | 2019 |
Thrombotic complications in adult patients with severe single coagulation factor or platelet defects – an overview
H Skaadel, Ø Bruserud |
Expert Review of Hematology | 2019 |
Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders
G Tiscia, M Margaglione |
International journal of molecular sciences | 2018 |
Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics
M Yazaki, T Yoshinaga, Y Sekijima, F Kametani, N Okumura |
International journal of molecular sciences | 2018 |
VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants
C Garnier, F Briki, B Nedelec, PL Pogamp, A Dogan, N Rioux-Leclercq, R Goude, C Beugnet, L Martin, M Delpech, F Bridoux, G Grateau, J Doucet, P Derreumaux, S Valleix |
Blood | 2017 |
Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications
Y Amri, C Kallel, M Becheur, R Dabboubi, M Elloumi, H Belaaj, S Kammoun, T Messaoud, P Moerloose, NE Toumi |
Clinica Chimica Acta | 2016 |
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management
A Casini, M Neerman-Arbez, RA Ariëns, P Moerloose |
Journal of Thrombosis and Haemostasis | 2015 |
Natural history of patients with congenital dysfibrinogenemia
A Casini, M Blondon, A Lebreton, J Koegel, V Tintillier, E Maistre, P Gautier, C Biron, M Neerman-Arbez, P Moerloose |
Blood | 2014 |
Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age
R Ramanathan, J Gram, S Feddersen, M Nybo, A Larsen, JJ Sidelmann |
Scandinavian Journal of Clinical & Laboratory Investigation | 2013 |
Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease: FIBA-derived peptides in AD
M Noguchi, T Sato, K Nagai, I Utagawa, I Suzuki, M Arito, N Iizuka, N Suematsu, K Okamoto, T Kato, N Yamaguchi, MS Kurokawa |
International Journal of Geriatric Psychiatry | 2013 |
Identification of N-homocysteinylation sites in plasma proteins
M Sikora, Ł Marczak, J Kubalska, AŁ Graban, H Jakubowski |
Amino Acids | 2013 |
Homocysteine in Protein Structure/Function and Human Disease
H Jakubowski |
2013 | |
Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin
DL Sauls, M Warren, M Hoffman |
Thrombosis Research | 2011 |
Textbook of Hemophilia
A Goodeve |
Textbook of Hemophilia | 2010 |
Modification of fibrin structure as a possible cause of thrombolytic resistance
B Lipinski |
Journal of Thrombosis and Thrombolysis | 2009 |
Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BβGly15Cys (Hamamatsu II)
Y Kamijyo, M Hirota-Kawadobora, K Yamauchi, F Terasawa, T Honda, M Ikeya, N Okumura |
Blood Coagulation & Fibrinolysis | 2009 |
Common variation in the C-terminal region of the fibrinogen -chain: effects on fibrin structure, fibrinolysis and clot rigidity
R Ajjan, BC Lim, KF Standeven, R Harrand, S Dolling, F Phoenix, R Greaves, RH Abou-Saleh, S Connell, DA Smith, JW Weisel, PJ Grant, RA Ariens |
Blood | 2008 |
Dysfibrinogen Kagoshima with the amino acid substitution γThr-314 to Ile: Analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule
K Niwa, J Mimuro, M Miyata, T Sugo, T Ohmori, S Madoiwa, C Tei, Y Sakata |
Thrombosis Research | 2008 |
A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux A Arg439Cys
M Hanss, C Vergnes, L Rugeri, P Ffrench, PD Mazancourt |
Journal of Thrombosis and Haemostasis | 2008 |
Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias
M Hill, G Dolan |
Haemophilia | 2008 |
Structural analyses of fibrinogen amyloid fibrils
LC Serpell, M Benson, JJ Liepnieks, PE Fraser |
Amyloid | 2007 |
Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia
DL Sauls, EK Arnold, CW Bell, JC Allen, M Hoffman |
Thrombosis Research | 2007 |
NMR Solution Structure, Stability, and Interaction of the Recombinant Bovine Fibrinogen αC-Domain Fragment
RA Burton, G Tsurupa, RR Hantgan, N Tjandra, L Medved |
Biochemistry | 2007 |
Direct Evidence for Specific Interactions of the Fibrinogen αC-Domains with the Central E Region and with Each Other
RI Litvinov, S Yakovlev, G Tsurupa, OV Gorkun, L Medved, JW Weisel |
Biochemistry | 2007 |
Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo
EL Kaijzel, P Koolwijk, MG van Erck, VW van Hinsbergh, MP de Maat |
Journal of Thrombosis and Haemostasis | 2006 |
New Insight into Alzheimer Disease: Demonstration of Fibrin(ogen)-serum Albumin Insoluble Deposits in Brain Tissue
B Lipinski, EM Sajdel-Sulkowska |
Alzheimer Disease & Associated Disorders | 2006 |
In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from γAsn319, Asp320 deletion dysfibrinogen, Otsu I
F Terasawa, S Kani, M Hongo, N Okumura |
Thrombosis Research | 2006 |
Fibrinogen Guarenas, an abnormal fibrinogen with an Aα-chain truncation due to a nonsense mutation at Aα 467 Glu (GAA)→stop (TAA)
R Marchi, Z Carvajal, M Meyer, J Soria, A Ruiz-Saez, CL Arocha-Piñango, JW Weisel |
Thrombosis Research | 2006 |
Les dysfibrinogènes
M Hanss |
Revue Francophone des Laboratoires | 2006 |
Modification of Fibrinogen by Homocysteine Thiolactone Increases Resistance to Fibrinolysis: A Potential Mechanism of the Thrombotic Tendency in Hyperhomocysteinemia
DL Sauls, E Lockhart, ME Warren, A Lenkowski, SE Wilhelm, M Hoffman |
Biochemistry | 2006 |
The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis
JP Collet, JL Moen, YI Veklich, OV Gorkun, ST Lord, G Montalescot, JW Weisel |
Blood | 2005 |
Natively unfolded regions of the vertebrate fibrinogen molecule
RF Doolittle, JM Kollman |
Proteins: Structure, Function, and Genetics | 2005 |
The mechanical properties of fibrin for basic scientists and clinicians
JW Weisel |
Biophysical Chemistry | 2004 |
Two novel fibrinogen variants found in patients with pulmonary embolism and their families
MM Hanss, PO Ffrench, JF Mornex, M Chabuet, F Biot, PD Mazancourt, M Dechavanne |
Journal of Thrombosis and Haemostasis | 2003 |
Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia
DL Sauls, AS Wolberg, M Hoffman |
Journal of Thrombosis and Haemostasis | 2003 |
Structure and function of human fibrinogen inferred from dysfibrinogens
M Matsuda, T Sugo |
International Journal of Hematology | 2002 |
Japanese Journal of Thrombosis and Hemostasis
M OKUDAIRA, H ASAKURA, Y SANO, Y SUGA, M YAMAZAKI, K AOSHIMA, E MORISHITA, M SAITO, Y ONTACHI, T MIZUTANI, M KATO, T ITO, K MIYAMOTO, S NAKAO |
Japanese Journal of Thrombosis and Hemostasis | 2001 |
Conformational Changes upon Conversion of Fibrinogen into Fibrin
L Medved, G Tsurupa, S Yakovlev |
Annals of the New York Academy of Sciences | 2001 |
Hereditary Disorders of Fibrinogen
M Matsuda, T Sugo |
Annals of the New York Academy of Sciences | 2001 |
The Structure and Function of the αC Domains of Fibrinogen
JW Weisel, L Medved |
Annals of the New York Academy of Sciences | 2001 |
Fibrinogen αC Domains Contain Cryptic Plasminogen and tPA Binding Sites
G Tsurupa, L Medved |
Annals of the New York Academy of Sciences | 2001 |
Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation
A Collen, A Maas, T Kooistra, F Lupu, J Grimbergen, FJ Haas, DH Biesma, P Koolwijk, J Koopman, VW van Hinsbergh |
Blood | 2001 |
Thrombotic Dysfibrinogenemia
R Marchi, SS Mirshahi, C Soria, M Mirshahi, M Zohar, JP Collet, NB de Bosch, CL Arocha-Piñango, J Soria |
Thrombosis Research | 2000 |
Structure and function of fibrinogen inferred from hereditary dysfibrinogens
M Matsuda |
Fibrinolysis and Proteolysis | 2000 |
Identification and Characterization of Novel tPA- and Plasminogen-Binding Sites within Fibrin(ogen) αC-Domains
G Tsurupa, L Medved |
Biochemistry | 2000 |
Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome
T Tarumi, D Martincic, A Thomas, R Janco, M Hudson, P Baxter, D Gailani |
Blood | 2000 |
End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure
T Sugo, C Nakamikawa, N Yoshida, K Niwa, M Sameshima, J Mimuro, JW Weisel, A Nagita, M Matsuda |
Blood | 2000 |
A Novel Apolipoprotein A-1 Variant, Arg173Pro, Associated with Cardiac and Cutaneous Amyloidosis
KH Asl, JJ Liepnieks, M Nakamura, F Parker, MD Benson |
Biochemical and Biophysical Research Communications | 1999 |
Thermal conformational changes of bovine fibrinogen by differential scanning calorimetry and circular dichroism
Y Chen, H Mao, X Zhang, Y Gong, N Zhao |
International Journal of Biological Macromolecules | 1999 |
Fibrinogen Act chain mutation (Arg554 Leu) associated with hereditary renal amyloidosis in a French family
LH Asl, V Fournier, C Billerey, E Justrabo, D Chevet, D Droz, C Pécheux, M Delpech, G Grateau |
Amyloid | 1998 |
Factor XIIIa Cross-Linking of the Marburg Fibrin: Formation of αm·γn-Heteromultimers and the α-Chain–Linked Albumin·γ Complex, and Disturbed Protofibril Assembly Resulting in Acquisition of Plasmin Resistance Relevant to Thrombophila
T Sugo, C Nakamikawa, M Takebe, I Kohno, R Egbring, M Matsuda |
Blood | 1998 |
γ-Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the γ Chain of Human Fibrinogen
HC Côté, S T., KP Pratt |
Blood | 1998 |
The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome"
MW Mosesson, KR Siebenlist, J Hainfeld, JS Wall, J Soria, C Soria, JP Caen |
Journal of Clinical Investigation | 1996 |
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots
JP Collet, JL Woodhead, J Soria, C Soria, M Mirshahi, JP Caen, JW Weisel |
Biophysical Journal | 1996 |
The Ultrastructure of Fibrinogen Caracas II Molecules, Fibers, and Clots
JL Woodhead, C Nagaswami, M Matsuda, CL Arocha-Piñango, JW Weisel |
The Journal of biological chemistry | 1996 |
Factor XIIIa-Catalyzed Cross-Linking of Recombinant αC Fragments of Human Fibrinogen
YV Matsuka, LV Medved, MM Migliorini, KC Ingham |
Biochemistry | 1996 |
Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation
EG Wojcik, M Berg, IK van der Linden, SR Poort, R Cupers, RM Bertina |
Biochemical Journal | 1995 |
CLINICAL AND LABORATORY EVALUATION OF THE HYPERCOAGULABLE STATES
BG Macik, TL Ortel |
Clinics in Chest Medicine | 1995 |
Hereditary renal amyloidosis with a novel variant fibrinogen
T Uemichi, JJ Liepnieks, MD Benson |
Journal of Clinical Investigation | 1994 |
Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: Its implication in atherogenesis and thromboembolism disease
JP Collet, Z Mishal, M Vasse, M Mirshahi, JP Caen, C Soria, J Soria |
Thrombosis Research | 1994 |
11 The molecular genetics of familial venous thrombosis
DN Cooper |
Baillière's Clinical Haematology | 1994 |
Role of the .alpha.C Domains of Fibrin in Clot Formation
OV Gorkun, YI Veklich, LV Medved', AH Henschen, JW Weisel |
Biochemistry | 1994 |
Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin
C Legrand, V Morandi, S Mendelovitz, H Shaked, JR Hartman, A Panet |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III
M Furlan, C Steinmann, M Jungo, C Bögli, F Baudo, R Redaelli, F Fedeli, B Lämmle |
The Journal of biological chemistry | 1994 |
Letter to the editor
MA Gillman, FJ Lightigfeld |
PAIN | 1981 |